top of page
BG Header.png
LOGO.png

ATA Posters & Audio

Batoclimab Induces Very Rapid and Sustained Post-treatment Euthyroidism in Graves’ Disease

Kahaly GJ,¹ Wolf J,¹ Ganz AL,¹ Luffy M,¹ Albert K,² Ali F,² Lin E,² Macias W²

¹Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany; ²Immunovant, Inc., New York, NY, USA

Treatment Utilization Patterns Among Patients Newly Diagnosed with Graves’ Disease: A Real-World Analysis

Lesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³
¹Immunovant, Inc., New York, NY, USA; ²Merative, Ann Arbor, MI, USA; ³Mayo Clinic, Rochester, MN, USA

Incidence and Costs of Adverse Events Following Initiation of Pharmacologic Treatment Used to Manage Graves’ Disease: A Real-World Analysis

Lesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³

¹Immunovant, Inc., New York, NY, USA; ²Merative, Ann Arbor, MI, USA; ³Mayo Clinic, Rochester, MN, USA

bottom of page